Elanco To Acquire Bayer's Animal Health Business For $7.6B

Elanco Animal Health Inc ELAN shares were trading lower Tuesday after the company announced it would acquire Bayer AG BAYRY's animal health business for $5.32 billion in cash and $2.28 billion in Elanco shares. The transaction is valued at $7.6 billion.

The deal is expected to double Elanco's companion animal business and create a balance between its food animal and companion animal segments.

"In our first four quarters as an independent company, we have validated the significant value creation potential from a dedicated focus on animal health and a targeted strategy," Elanco CEO Jeffrey Simmons said in a statement. 

"Joining Elanco and Bayer Animal Health strengthens and accelerates our IPP strategy, transforms our portfolio with the addition of well-known pet brands, brings an increased presence in key emerging markets, expands innovation and accelerates our margin expansion journey."

Elanco Animal Health shares were trading down 4.63% at $28.40 at the time of publication Tuesday. The stock has a 52-week high of $37.61 and a 52-week low of $28.

Related Links:

Estee Lauder Reports Q4 Earnings Beat, Raises Guidance

Weibo Trades Higher On Q2 Earnings Beat

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: M&ANews
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!